Jeff Jones
Stock Analyst at Oppenheimer
(0)
# 4341
Out of 5,218 analysts
95
Total ratings
21.43%
Success rate
-9.08%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Cellectar Bioscience... | Downgrades: Perform | n/a | n/a | n/a | 5 | Dec 11, 2024 | |
Perspective Therapeu... | Maintains: Outperform | 22 16 | 3.45 | 363.77% | 7 | Nov 22, 2024 | |
Evolent Health | Maintains: Outperform | 34 28 | 11.36 | 146.48% | 3 | Nov 18, 2024 | |
Y-mAbs Therapeutics | Initiates Coverage On: Outperform | 23 | 9.37 | 145.46% | 1 | Nov 18, 2024 | |
Chemomab Therapeutic... | Reiterates: Outperform | 13 11 | 1.59 | 591.82% | 7 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 8 14 | 7.35 | 90.48% | 3 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 10 9 | 2.27 | 296.48% | 10 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 52 56 | 41.98 | 33.4% | 4 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 35 39 | 26.59 | 46.67% | 2 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 87 89 | 28.93 | 207.64% | 1 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 48 45 | 13.2 | 240.91% | 6 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 80 88 | 15.13 | 481.63% | 8 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 4 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 16 21 | 2.29 | 817.03% | 2 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Perform | n/a | n/a | n/a | 3 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 13 15 | n/a | n/a | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 120 | 0.38 | 31478.95% | 3 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 2 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 13 | n/a | n/a | 2 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 15 | 1.58 | 849.37% | 5 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 75 | 2.34 | 3105.13% | 2 | Mar 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 125 150 | n/a | n/a | 6 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 160 110 | 1.15 | 9465.22% | 2 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Outperform | 193 | n/a | n/a | 1 | Jul 18, 2022 |